Mant M J
Department of Medicine, University of Alberta, Edmonton, Canada.
J Intern Med. 1994 Nov;236(5):593-5. doi: 10.1111/j.1365-2796.1994.tb00851.x.
A patient with chronic idiopathic pure red cell hypoplasia responded to intravenous immunoglobulin therapy. No other treatment was administered. During treatment, the patient was taken through two pregnancies without haematological problems. After 22 months of therapy, the intravenous immunoglobulin was discontinued; a durable remission was subsequently maintained. Intravenous immunoglobulin may be the treatment of choice for females of child-bearing potential.
一名患有慢性特发性纯红细胞再生障碍性贫血的患者对静脉注射免疫球蛋白治疗有反应。未给予其他治疗。在治疗期间，该患者经历了两次妊娠，未出现血液学问题。治疗22个月后，停止静脉注射免疫球蛋白；随后维持了持久的缓解。静脉注射免疫球蛋白可能是有生育潜力女性的首选治疗方法。
